Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer

Name: Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer
License: Public Domain

The First Affiliated Hospital of Guangzhou Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

irae, hematologic disorder, lung cancer (locally advanced or metastatic)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 249585
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.